Erythrocyte fatty acids of fish oil supplemented children and controls
| Fatty acids | Controls (n = 7) | Fish oil (n = 10) | |||||
|---|---|---|---|---|---|---|---|
| Baseline | 9 weeks | Baseline | 9 weeks | ||||
| ω3 series | |||||||
| 18:3ω3 | 0.16 (0.05) | 0.15 (0.05) | 0.18 (0.12) | 0.22 (0.14) | |||
| 20:5ω3 | 0.26 (0.08) | 0.29 (0.17) | 0.31 (0.33) | 0.72 (0.42)3-150 3-153 | |||
| 22:5ω3 | 1.62 (0.35) | 1.52 (0.47) | 1.51 (0.75) | 2.08 (0.92)3-151 | |||
| 22:6ω3 | 2.11 (0.49) | 2.07 (0.71) | 2.27 (0.81) | 3.35 (0.76)3-151 3-153 | |||
| ω6 series | |||||||
| 18:2ω6 | 9.94 (1.99) | 9.80 (2.24) | 7.43 (1.52) | 7.83 (1.99) | |||
| 20:2ω6 | 0.23 (0.07) | 0.21 (0.10) | 0.18 (0.06) | 0.21 (0.07) | |||
| 20:3ω6 | 1.53 (0.17) | 1.48 (0.17) | 1.32 (0.39) | 1.39 (0.29) | |||
| 20:4ω6 | 14.03 (1.11) | 13.62 (1.73) | 13.01 (3.40) | 13.04 (1.49) | |||
| 22:4ω6 | 3.27 (0.36) | 2.91 (0.46) | 2.64 (0.71) | 2.43 (0.48) | |||
| 22:5ω6 | 0.95 (0.17) | 0.89 (0.18) | 0.92 (0.27) | 0.82 (0.17) | |||
| ω9 series | |||||||
| 18:1ω9 | 10.95 (1.07) | 11.10 (1.39) | 12.90 (1.44) | 12.33 (1.62) | |||
| 20:1ω9 | 0.22 (0.04) | 0.23 (0.04) | 0.25 (0.05) | 0.22 (0.06) | |||
| 20:3ω9 | 0.35 (0.09) | 0.43 (0.28) | 0.60 (0.44) | 0.60 (0.32) | |||
| 22:3ω9 | 0.18 (0.12) | 0.16 (0.13) | 0.29 (0.22) | 0.23 (0.14) | |||
| 24:1ω9 | 3.66 (0.37) | 3.38 (0.42) | 4.08 (0.49) | 3.94 (0.49)3-154 | |||
| SAFA | 48.59 (0.66) | 50.04 (3.93) | 50.24 (5.13) | 48.88 (1.38) | |||
| MUFA | 16.78 (1.44) | 16.44 (1.57) | 19.14 (1.53) | 18.20 (1.53) | |||
| PUFA | 34.64 (1.95) | 33.53 (3.75) | 30.64 (5.93) | 32.91 (2.17) | |||
| Sumω3 | 4.16 (0.79) | 4.03 (1.24) | 4.26 (1.71) | 6.37 (1.66)3-150 3-153 | |||
| Sumω6 | 29.95 (1.73) | 28.91 (3.34) | 25.51 (5.00) | 25.70 (3.13) | |||
| Sumω7 | 1.91 (0.43) | 1.70 (0.51) | 1.83 (0.50) | 1.67 (0.32) | |||
| Sumω9 | 15.40 (1.41) | 15.33 (1.76) | 18.15 (1.96) | 17.37 (2.11) | |||
| LCPUFAω3 | 3.99 (0.79) | 3.88 (1.22) | 4.08 (1.60) | 6.15 (1.54)3-150 3-152 | |||
| LCPUFAω6 | 19.78 (1.43) | 18.90 (2.06) | 17.90 (4.53) | 17.68 (2.01) | |||
| ω3/ω6 | 0.14 (0.03) | 0.14 (0.05) | 0.17 (0.08) | 0.26 (0.103-150 3-153 | |||
| LCω3/LCω6 | 0.20 (0.03) | 0.20 (0.06) | 0.23 (0.09) | 0.35 (0.11)3-150 3-152 | |||
Data represent mean (SD) and are expressed as mol% (mol/100 mol). For abbreviations see table 1. Controls received nutritional rehabilitation for 9.7 weeks (range 8–16); the fish oil group was additionally supplemented with 500 mg fish oil (see table 1) daily for 9.1 weeks (range 7–12).
↵3-150 Significant difference between baseline and 9 weeks at p ⩽ 0.005.
↵3-151 Significant difference between baseline and 9 weeks at p ⩽ 0.01.
↵3-152 Significant difference between fish oil and control group at p ⩽ 0.005.
↵3-153 Significant difference between fish oil and control group at p ⩽ 0.01.
↵3-154 Significant difference between fish oil and control group at p ⩽ 0.05.